CL King Upgrades IDEXX Laboratories (IDXX) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $560.38 -1.13%
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
CL King upgraded IDEXX Laboratories (NASDAQ: IDXX) from Neutral to Buy with a price target of $200.00.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $164.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Goldman Sachs (GS) to Buy
- RBC Capital Upgrades Sartorius AG (SRT3:GR) (SARTF) to Outperform
- Scotiabank Upgrades Rumo SA (RAIL3:BZ) to Sector Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
CL KingSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
